People: Cooper Companies Inc (COO)

Summary

Name	Age	Since	Current Position
A. Thomas Bender	73	2007	Independent Chairman of the Board
Robert Weiss	66	2008	President, Chief Executive Officer, Non-Independent Director
Allan Rubenstein	67	2002	Independent Vice Chairman of the Board, Lead Director
Gregory Matz	53	2011	Chief Financial Officer, Vice President
Nicholas Pichotta	68	2012	President and Chief Executive Officer of Cooper Medical, Inc.
Paul Remmell	55	2012	President and Chief Executive Officer of CooperSurgical Inc.
John Weber	50	2008	President of CooperVision, Inc.
Carol Kaufman	63	2011	Executive Vice President, Chief Administrative Officer, Secretary
Daniel McBride	48	2011	Vice President, Chief Risk Officer, General Counsel
Rodney Folden	65	2009	Vice President, Corporate Controller
Albert White	43	2013	Vice President - Investor Relations, Chief Strategic Officer
Eugene Midlock	68	2011	Vice President - Taxes
Michael Kalkstein	70	1992	Independent Director
Jody Lindell	61	2006	Independent Director
Gary Petersmeyer	65	2013	Independent Director
Donald Press	79	1993	Independent Director
Steven Rosenberg	54	1993	Independent Director
Stanley Zinberg	78	1997	Independent Director
Kim Duncan			IR Contact Officer

» Insider Trading

Biographies

Name	Description
A. Thomas Bender	Mr. A. Thomas Bender is Independent Chairman of the Board of Cooper Companies Inc. Mr. Bender has served on Company's Board since 1994 and was elected Chairman in July 2002. He also served as Company's President and Chief Executive Officer from May 1995 until his retirement in October 2007. He previously served as President of CooperVision, Company's contact lens subsidiary, from June 1991 to December 2004. Between 1966 and June 1991, Mr. Bender held a variety of management positions at Allergan, Inc., a manufacturer of eye and skin care products, including Corporate Senior Vice President, and President and Chief Operating Officer of Herbert Laboratories, Allergan’s dermatology division. Mr. Bender serves on the board of directors of Allegro Ophthalmics LLC, a private ophthalmic company focused on pharmaceutical treatment of eye disease, and on the board of Mission Hospital Foundation in Mission Viejo, CA.
Robert Weiss	Mr. Robert S. Weiss is President, Chief Executive Officer, Non-Independent Director of Cooper Companies Inc. Mr. Weiss has served as Company's President since March 2008 and as Company's Chief Executive Officer since November 2007. He also served as President of CooperVision, Company's contact lens subsidiary, from March 2007 to February 2008. He previously served as Company's Chief Operating Officer from January 2005 to October 2007 and as Executive Vice President from October 1995 to October 2007. He served as Company's Chief Financial Officer from September 1989 to January 2005. He served as Company's Treasurer from 1989 to March 2002. Since joining the Company in 1977, he has held a number of finance positions both with the Company and Cooper Laboratories, Inc. (Company's former parent). Mr. Weiss is also a director of Accuray Incorporated (Nasdaq: ARAY), a company that develops, manufactures and markets sophisticated robotic radiosurgery and radiation therapy systems designed to treat tumors. He serves on its nominating committee and as chair of its audit committee.
Allan Rubenstein	Dr. Allan E. Rubenstein, M.D., is Independent Vice Chairman of the Board, Lead Director of Cooper Companies Inc., since July 2002. Previously he served as Chairman of the Board from July 1994 through July 2002. He served as Acting Chairman of the Board from April 1993 through June 1994. He currently serves as Clinical Professor of Neurology and Pediatrics at New York University Langone Medical Center. He also founded NexGenix Pharmaceuticals and served as its Chief Executive Officer until September 2012. He currently serves as chairman of the board of directors for CalAsia Pharmaceuticals, Inc., a biotechnology company based in San Diego, California. Previously, he has served as a director of BioClinica (NASDAQ: BIOC), a specialty clinical trials company, from 2000 to 2003 and is also Medical Director Emeritus of the Children’s Tumor Foundation and a consultant to the National Institutes of Health, the U.S. Food and Drug Administration and the U.S. Department of Defense, where he served as Chair of the Army Neurofibromatosis Research Program Integration Panel in 2001.
Gregory Matz	Mr. Gregory W. Matz is Chief Financial Officer, Vice President of Cooper Companies Inc., since December 2011. Previously he served as Company's Vice President, Finance from July 2011 to December 2011. He joined CooperVision, Inc. in May 2010 as Vice President and Chief Financial Officer and served in that position until October 2011. Prior to joining CooperVision, he has spent 25 years in the Electronic Measurement, Chemical Analysis and Life Science markets. Prior to joining the Company he served in a variety of senior management roles at Agilent Technologies Inc. from 1999-2010, including Vice President and Controller of the Wireless Business Unit, Vice President and Director of Internal Audit and Assistant Corporate Controller. Prior to Agilent, Mr. Matz worked at Hewlett Packard from 1984-1999 in a variety of financial and marketing roles. Mr. Matz started his career at KPMG in San Francisco from 1981-1984. Mr. Matz is a Certified Public Accountant.
Nicholas Pichotta	Mr. Nicholas J. Pichotta is President and Chief Executive Officer of Cooper Medical, Inc., a subsidiary Company of Cooper Companies Inc. Mr. Pichotta serves as President and Chief Executive Officer of Cooper Medical, Inc., the parent company of CooperSurgical, Company's women's healthcare business. Previously, he served as Chief Executive Officer of CooperSurgical from September 1992 to December 2011, where he was primarily responsible for all merger and acquisition activity. He also served as President of CooperSurgical from September 1992 to December 2004. Prior to that he held various management positions with the Company from September 1989.
Paul Remmell	Mr. Paul L. Remmell is President and Chief Executive Officer of CooperSurgical Inc., a subsidiary Company of Cooper Companies Inc. Mr. Remmell has been Chief Executive Officer of CooperSurgical, Company's women’s health care business, since January 2012 and he has served as President of CooperSurgical, since December 2004. He previously served as Chief Operating Officer of CooperSurgical from October 2000 to January 2012 and as Vice President of Finance from 1991 to December 2004.
John Weber	Mr. John Arthur Weber is President of CooperVision Inc., a subsidiary Company of Cooper Companies Inc., since February 2008. Prior to that he served as President, Asia Pacific of CooperVision from April 2007 to February 2008 and as Vice President, Worldwide Manufacturing and Distribution of CooperVision from January 2005 to March 2007. He previously served as Executive Vice President, Worldwide Operations of Ocular Sciences from July 2003 to December 2004 and as Vice President, Manufacturing of Ocular Sciences from January 2001 to July 2003. Mr. Weber served in various other management positions at Ocular Sciences between 1993 and 2001.
Carol Kaufman	Ms. Carol R. Kaufman is Executive Vice President, Chief Administrative Officer, Secretary of Cooper Companies Inc. Ms. Kaufman has served as Executive Vice President since July 2011. She previously served as Senior Vice President of Legal Affairs from December 2004. She has also served as Vice President and Chief Administrative Officer since October 1995 and as Vice President and Secretary since March 1996. From January 1989 through September 1995, she served as Vice President, Secretary and Chief Administrative Officer of Cooper Development Company, a health care and consumer products company. She previously held a variety of financial positions with Cooper Laboratories, Inc. (Company's former parent) since joining that company in 1971. Ms. Kaufman currently serves as a director for Chindex, Inc. (NASDAQ: CHDX), a publicly traded provider of health care services in China, and is a member of its audit and compensation committees and chair of the governance and nominating committee of its board of directors.
Daniel McBride	Mr. Daniel G. McBride, Esq., is Vice President, Chief Risk Officer, General Counsel of Cooper Companies Inc. Mr. McBride has served as Chief Risk Officer since July 2011, as Company's General Counsel since November 2007 and as Vice President since July 2006. He also served as Senior Counsel from February 2005 through November 2007. Prior to joining the Company, Mr. McBride was an attorney with Latham & Watkins LLP from October 1998 to February 2005, concentrating on mergers and acquisitions and corporate finance matters.
Rodney Folden	Mr. Rodney E. Folden is Vice President, Corporate Controller of Cooper Companies Inc. Mr. Folden has served as Vice President since March 2009 and as Corporate Controller since February 2004. He served as Assistant Corporate Controller from March 1994 to February 2004. He has also held a variety of financial positions within the Company since joining the Company in 1987.
Albert White	Mr. Albert G. White, III, is Vice President - Investor Relations, Chief Strategic Officer of Cooper Companies Inc. Mr. White has served as Chief Strategic Officer since July 2011 and as Vice President, Investor Relations since November 2007. He also served as Vice President and Treasurer from April 2006 until January 2013. Prior to joining the Company he served as a Director with KeyBanc Capital Markets for three years and in a number of leadership positions within KeyBank National Association.
Eugene Midlock	Mr. Eugene J. Midlock is Vice President - Taxes of Cooper Companies Inc. Previously he served as Senior Vice President and Chief Financial Officer from February 2008 to December 2011. Prior to that he served as the Vice President, Finance from November 2007 to February 2008 and as Vice President, Taxes from January 2005 to October 2007. From November 2003 until December 2004 he served as Company's consultant. During this period he also served as an instructor in the Master of Science in Taxation program of San Jose State University. From 1979 until he retired in 2002 he was a partner and held a number of leadership positions with KPMG.
Michael Kalkstein	Mr. Michael H. Kalkstein is Independent Director of Cooper Companies Inc. Mr. Kalkstein was a partner at Dechert LLP, an international law firm, from June 2003 through June 2007 and was Co-chair of the firm’s Intellectual Property Practice Group. He also served as the Managing Partner of Dechert’s Palo Alto office from June 2003 through December 2005. As of June 30, 2007, he has retired from active practice and continues to be “Of Counsel” to Dechert at its Mountain View, CA office. Previously, from September 1999 through May 2003, he was a partner at Oppenheimer, Wolff & Donnelly, LLP, an international law firm, and a member of its Policy and Technologies Committees. Mr. Kalkstein serves on the Board of Governors of The Silicon Valley Capital Club. He previously served as a member of the Board of Trustees of Opera San Jose from 1984 to October 2010, serving as its President from 1992 to 1994. He was a member of the Alliance of CEOs from 2001 to June 2007 and was a member of the board of directors of the Law Foundation of Silicon Valley from 2002 to June 2007. Until January 2007, he also served as a director of the Northern California Chapter of the National Association of Corporate Directors.
Jody Lindell	Ms. Jody S. Lindell is Independent Director of Cooper Companies Inc. Ms. Lindell is President and Chief Executive Officer of S.G. Management, Inc., an asset management company she has headed since 2000. Until May 2000, Ms. Lindell was a partner with KPMG LLP where she served as Partner-In-Charge of the Industrial Markets and Healthcare and Life Sciences practices for the Western Area. Ms. Lindell is also a Certified Public Accountant (inactive). Through September 2007, she served as a director and on the audit and director’s loan committees for First Republic Bank, a publicly traded financial institution. First Republic Bank was acquired in 2007, underwent a management led buyout in mid-2010 and again became publicly traded (NYSE: FRC) in December 2010. Ms. Lindell continues to serve as a director, chairs the audit committee and serves on the director’s loan committee and the director’s trust committee for First Republic Bank. She also currently serves on the board of directors and the audit, compensation and nominating and corporate governance committees of PDL BioPharma (NasdaqGS: PDLI).
Gary Petersmeyer	Mr. Gary S. Petersmeyer is Independent Director of Cooper Companies Inc. Mr. Petersmeyer currently serves as a consultant to companies in the pharmaceutical and medical device industries. Most recently he co-founded Aesthetic Sciences Corporation in 2004 and served as the Chief Executive Officer and Chairman until December 2010. Prior to that he served as President and Chief Operating Officer of Pherin Pharmaceuticals, Inc. from 2000 to 2001, and as President and Chief Operating Officer of Collagen Corporation, Inc. from 1995 to 2000. From 1976 to 2000 he served in various management positions for pharmaceutical and medical device companies. Mr. Petersmeyer serves as a director and member of the compensation and audit committees of Omnicell, Inc. (NASDAQ: OMCL). He has served on the boards of Visx Incorporated and Roxro Pharmaceuticals prior to their acquisitions. He also serves as chairman of the board for Positive Coaching Alliance, a non-profit organization dedicated to improving youth sports.
Donald Press	Mr. Donald Press is Independent Director of Cooper Companies Inc. Mr. Press is Executive Vice President of Broadway Management Co., Inc., an owner and manager of commercial office buildings, and has served in this position since 1981. Mr. Press is also a principal in Donald Press, P.C., a law firm, located in New York City. He is a practicing attorney and has represented clients in a wide range of businesses for over 30 years. Mr. Press is a director of The Berkshire Bank, a wholly owned subsidiary of Berkshire Bancorp Inc., and he serves on its audit committee.
Steven Rosenberg	Mr. Steven P. Rosenberg is Independent Director of Cooper Companies Inc. Mr. Rosenberg is President and Chief Executive Officer of Berkshire Bancorp Inc., a publicly traded bank holding company (NASDAQ: BERK), and has held this position since March 1999. He also served as Vice President, Finance and Chief Financial Officer from March 1990 to March 1999. From September 1987 through March 1990, Mr. Rosenberg was President and Chief Executive Officer of Scomel Industries, Inc., an international marketing and consulting group. Prior to that, he was Vice President of Noel Industries, Inc., an apparel manufacturer and importer. He is currently a director of Berkshire Bancorp Inc.
Stanley Zinberg	Dr. Stanley Zinberg, M.D., is Independent Director of Cooper Companies Inc. Dr. Zinberg is a retired obstetrician-gynecologist who served as Deputy Executive Vice President and Vice President of Practice Activities for the American College of Obstetricians and Gynecologists (ACOG) in Washington, D.C. from 1993 through his retirement in December 2007. From 1981 until 1993 he served as Chief, Obstetrics and Gynecology, and Director, OB-GYN Residency Program at NY Downtown Hospital, where from 1990 through 1992 he also served as President of the Medical Staff. He is certified by the American Board of Obstetrics and Gynecology and is a member of the faculty of the Departments of Obstetrics and Gynecology at New York University School of Medicine, the Cornell University College of Medicine and the Georgetown University School of Medicine. He is the author of numerous editorials, scientific papers and book chapters in the field of women’s health care. In addition, Dr. Zinberg obtained a Masters Degree in Health Administration, with an emphasis on not-for-profit finance, in 1990 from the Graduate School of Public Administration of New York University. Currently, Dr. Zinberg is a member of the Board of Trustees of the New York Downtown Hospital and is a director of the Peconic Bay Medical Center Foundation. In addition, he is a director of the Westhampton Beach Performing Arts Center, a member of the New York State Board for Professional Medical Conduct, and a member of the Southampton Town Board of Ethics in Southampton, NY.
Kim Duncan

Basic Compensation

Name	Fiscal Year Total
A. Thomas Bender	969,734
Robert Weiss	5,417,450
Allan Rubenstein	--
Gregory Matz	1,527,420
Nicholas Pichotta	1,399,730
Paul Remmell	1,166,760
John Weber	1,957,760
Carol Kaufman	2,052,850
Daniel McBride	--
Rodney Folden	801,891
Albert White	1,533,910
Eugene Midlock	1,090,680
Michael Kalkstein	--
Jody Lindell	--
Gary Petersmeyer	--
Donald Press	--
Steven Rosenberg	--
Stanley Zinberg	--
Kim Duncan	--

As Of 30 Oct 2012

Options Compensation

Name	Options	Value
A. Thomas Bender	646,000	11,711,540
Robert Weiss	574,000	13,419,580
Allan Rubenstein	0	0
Gregory Matz	0	0
Nicholas Pichotta	130,725	1,413,500
Paul Remmell	0	0
John Weber	47,625	2,668,830
Carol Kaufman	259,500	7,230,370
Daniel McBride	0	0
Rodney Folden	16,000	394,300
Albert White	33,625	2,051,310
Eugene Midlock	54,625	1,631,420
Michael Kalkstein	0	0
Jody Lindell	0	0
Gary Petersmeyer	0	0
Donald Press	0	0
Steven Rosenberg	0	0
Stanley Zinberg	0	0
Kim Duncan	0	0

Insider Trading

Name	Shares Traded	Price
BENDER A THOMAS	5,000	$108.04
REMMELL PAUL L	6,600	$13.10
REMMELL PAUL L	15,488	$108.83
REMMELL PAUL L	4,125	$13.21
PRESS DONALD	7,500	$69.39
PRESS DONALD	7,500	$108.07
WEBER JOHN ARTHUR	23,304	$67.65
WEBER JOHN ARTHUR	23,304	$107.19
FOLDEN RODNEY E	20,000	$67.65
FOLDEN RODNEY E	20,000	$107.02
MCBRIDE DANIEL G	6,000	$13.10
PRESS DONALD	10,000	$69.39
MCBRIDE DANIEL G	15,000	$107.50
MCBRIDE DANIEL G	6,000	$107.50
MCBRIDE DANIEL G	15,000	$13.21
PRESS DONALD	10,000	$107.50
PICHOTTA NICHOLAS J	6,600	$105.50
PICHOTTA NICHOLAS J	4,125	$105.50
PICHOTTA NICHOLAS J	6,600	$13.10
PICHOTTA NICHOLAS J	4,363	$105.50
PICHOTTA NICHOLAS J	4,125	$13.21
WEBER JOHN ARTHUR	6,061	$104.28
WEISS ROBERT S	20,000	$13.21
KAUFMAN CAROL R	35,500	$41.44
KAUFMAN CAROL R	5,304	$106.09

» Full list on Insider Trading

People: Cooper Companies Inc (COO)

Related Topics:

Summary

Biographies

Basic Compensation

Options Compensation

Related Topics: